Publications by authors named "V Westeel"

Claim this Profile
D
Durvalumab in Patients With Treatment-Naive Stage IV NSCLC With an ECOG Performance Status of 2 to 3 and High PD-L1 Tumor Expression (IFCT-1802 SAVIMMUNE): A Multicenter Phase 2 Trial.
Valérie Gounant, Laurent Greillier, Céline Mascaux, François Pinquie, Delphine Carmier, Virginie Westeel

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinctive computed tomography features of chronic obstructive pulmonary disease among dairy farmers and smokers.
Emeline Mourouvin-Chevolot, Lucie Laurent, Frederic Claudé, Virginie Westeel, Paul Calame

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
David R Spigel, Virginie Westeel, Ian C Anderson, Laurent Greillier, Florian Guisier

Lancet Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter Re "Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS".
Elisa Gobbini, Alexandra Langlais, Pascale Missy, Sébastien Chanoine, Benjamin Besse, Virginie Westeel

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting Airway Involvement in Non-Asthmatic Eosinophilic Disorders: Diagnostic Utility of Fractional Exhaled Nitric Oxide (FeNO).
Nicolas Raoul, Lucie Laurent, Ophélie Ritter, Pauline Roux-Claudé, Faraj Al Freijat, Virginie Westeel

Adv Respir Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis